HomeInsightsPE

Jubilant Pharmova Ltd PE Ratio

Jubilant Pharmova Ltd PE Ratio

stocks purchased

₹ 1.5 Cr

Volume transacted

stocks purchased

13.0 K

stocks traded

Last Updated time: 10 Oct 15:30 PM

Image

Jubilant Pharmova Ltd

NSE: JUBLPHARMA

PE

79.1

Last updated: 10 Oct 15:30 PM

Key Highlights

  • The P/E Ratio of Jubilant Pharmova Ltd is 79.1 as of 10 Oct 15:30 PM.
  • The P/E Ratio of Jubilant Pharmova Ltd changed from 18.4 on March 2019 to 116.5 on March 2024 . This represents a CAGR of 36.01% over 6 years. .
  • The Latest Trading Price of Jubilant Pharmova Ltd is ₹ 1183 as of 10 Oct 15:30.
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 21.8. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 158.1. The PE Ratio of Textiles industry is 37.6. In 2024.

Historical P/E Ratio of Jubilant Pharmova Ltd

No data available

Company Fundamentals for Jubilant Pharmova Ltd

No data available

Image

Jubilant Pharmova Ltd

NSE: JUBLPHARMA

PRICE

1183.8

19.05 (1.64%)

stock direction

Last updated: 10 Oct 15:30

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Jubilant Pharmova Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
10 Oct 20241183.8
09 Oct 20241164.75
08 Oct 20241139.9
07 Oct 20241081.55
04 Oct 20241115.15
03 Oct 20241117.45
01 Oct 20241167.55
30 Sep 20241151.9
27 Sep 20241168.25
26 Sep 20241178.6

SWOT Analysis Of Jubilant Pharmova Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Jubilant Pharmova Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Jubilant Pharmova Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Jubilant Pharmova Ltd

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Jubilant Pharmova Ltd

No data available

* All values are in crore

Historical Revenue of Jubilant Pharmova Ltd

No data available

* All values are in crore

Historical EBITDA of Jubilant Pharmova Ltd

No data available

* All values are in crore

Historical Net Profit of Jubilant Pharmova Ltd

No data available

* All values are in crore

Historical Dividend Payout of Jubilant Pharmova Ltd

No data available

* All values are in %

About Jubilant Pharmova Ltd

  • Jubilant Pharmova Limited, (Formerly known as Jubilant Life Sciences Limited), is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.
  • The Company is engaged in pharmaceuticals, contract research and development services and proprietary novel drugs.
  • The pharmaceuticals segment, through wholly owned subsidiary Jubilant Pharma Limited, is engaged in manufacture and supply of Active Pharmaceutical Ingredients (APIs), Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Contract Manufacturing of Sterile Injectables and Non-Sterile Products through 6 US FDA approved manufacturing facilities in India, USA and Canada with a network of over 48 radiopharmacies in the USA. The contract research and development segment provides drug discovery and development services as well as clinical data software and service solutions.

Jubilant Pharmova Ltd News Hub

News

Jubilant Pharmova gains as Washington unit gets VAI classification from USFDA

The United States Food & Drug Administration (USFDA) conducted an audit of the facility fr...

Read more

11 Sep 202410:52

News

Jubilant Pharmova Ltd leads gainers in 'A' group

Morepen Laboratories Ltd, La Opala RG Ltd, AGI Greenpac Ltd and Gujarat Alkalies & Chemica...

Read more

09 Sep 202412:00

News

Volumes soar at Jubilant Pharmova Ltd counter

Alembic Pharmaceuticals Ltd, Doms Industries Ltd, EPL Ltd, Anand Rathi Wealth Ltd are amon...

Read more

09 Sep 202414:30

News

Jubilant Biosys signs and issues a put option offer to Pierre Fabre Laboratories

Jubilant Biosys Innovative Research Services,, Singapore (JBIRSPL), subsidiary of Jubilant...

Read more

16 Aug 202418:41

News

Volumes soar at Jubilant Pharmova Ltd counter

Firstsource Solutions Ltd, Adani Energy Solutions Ltd, Sapphire Foods India Ltd, Lloyds Me...

Read more

01 Aug 202414:30

News

Jubilant Pharmova hits 52-week high after Q1 PAT zooms to Rs 482 cr

Total income increased by 9.41% to Rs 1,745.7 crore in Q1 FY25 as compared with Rs 1,595.5...

Read more

19 Jul 202415:06

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PE of Jubilant Pharmova Ltd

What is the current PE Ratio of Jubilant Pharmova Ltd?

The Current PE Ratio of Jubilant Pharmova Ltd is 79.13 as on 10 Oct 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 10 Oct 2024.

What was the PE Ratio of Jubilant Pharmova Ltd last year?

The PE Ratio of Jubilant Pharmova Ltd was 0.0 last year, now the PE ratio is 79.13, showing a year-on-year growth of -%.

What does the PE Ratio of Jubilant Pharmova Ltd indicate about its stock?

The PE Ratio of Jubilant Pharmova Ltd is 79.13. This ratio indicates that investors are willing to pay 79.13 times the earnings per share for each share of Jubilant Pharmova Ltd.

What is the PE Ratio Growth of Jubilant Pharmova Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Jubilant Pharmova Ltd grew by -% whereas, the EPS ratio grew by -924.9.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*